Airdate: Tuesday, May 16, 2023 Season: 10 Episode: 17
Guest: Jeffrey C. Silva
Dr. Jeffrey Silva and Dr. Matthew Stokes from Cell Signaling Technology answers questions from a recent webinar exploring the role of mass spectrometry-based proteomics on drug discovery, disease mechanisms, and biomarker identification.
For more information or to watch the webinar, click here.
Associated Webinar: Targeting Proteomics to Decipher Biology for the Drug Development Pipeline
Similar Podcasts
#ExpertAnswers: Jack Vanden Heuvel on Prediction Drug-Drug Interactions Early
Dr. Jack Vanden Heuvel from Penn State University and INDIGO Biosciences answers questions from a recent webinar where he discusses methodologies for predicting drug-drug interactions using in vitro assays and gene expression studies.
#ExpertAnswers: Catherine Ewen on Setting Up DC and CD8⁺ T Cell Co-culture Experiments
Dr. Catherine Ewen from STEMCELL Technologies answers questions from a recent webinar where she describes how to set up DC and CD8⁺ T cell co-culture experiments and assess T cell proliferation and activity.
#ExpertAnswers: Travis Hardcastle and Seth Hanson on Using CRISPR and iPSCs for Neuroscience Research
Travis Hardcastle and Seth Hanson answer questions from a webinar where they discuss innovative applications of CRISPR and iPSCs in disease modeling and drug discovery.
Related Content
Clambake: An Algorithm to Decode Energy Expenditure Data from Metabolic Cages
In this webinar, Dr. Jonathan Brestoff discusses his research on metabolism and a new method to quantify metabolic data known as Clambake.
Discover the Freshness of Frozen PBMCs – An Assessment of Cryopreservation Impact on T Cell Activation and Phenotype
Discover the impact of cryopreservation of PBMCs on T cell activation and phenotype in Lonza’s free webinar.
Applications of Humanized Mice in the Evaluation of Antibody-Drug Conjugates to Treat Autoimmune Diseases
Join experts from GemPharmatech and BioRay Pharmaceutical as they discuss the use of humanized mice to evaluate antibody-drug conjugates for treating autoimmune diseases.